Association between renal function and platelet reactivity during aspirin therapy in elderly patients with atherosclerotic cardiovascular disease
Abstract Background Aspirin is the key treatment in the secondary prevention of atherosclerotic cardiovascular disease. High on-treatment platelet reactivity (HTPR) to aspirin has been reported to partially account for the enhanced risk of thrombotic events. In particular, HTPR has been described mo...
Main Authors: | Wenyi Liang, Peng Zhang, Meilin Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | BMC Geriatrics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12877-021-02018-y |
Similar Items
-
Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease
by: Zhang JW, et al.
Published: (2017-08-01) -
vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease
by: Ellen M. K. Warlo, et al.
Published: (2017-11-01) -
Effect of madecassoside combined with aspirin on platelet functions
by: Theiarawat Kraikate, et al.
Published: (2015-09-01) -
Circadian Rhythm of Cardiovascular Disease: The Potential of Chronotherapy With Aspirin
by: Marleen Buurma, et al.
Published: (2019-06-01) -
ANTIAGGREGANT THERAPY AND REDUCTION OF HIGH RESIDUAL PLATELET REACTIVITY
by: N. A. Mazur, et al.
Published: (2012-08-01)